nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Depressed mood—Varenicline—nicotine dependence	0.0563	0.0698	CcSEcCtD
Labetalol—Sleep disturbance—Varenicline—nicotine dependence	0.0449	0.0557	CcSEcCtD
Labetalol—Nightmare—Varenicline—nicotine dependence	0.0243	0.0301	CcSEcCtD
Labetalol—Dry eye—Varenicline—nicotine dependence	0.0233	0.0288	CcSEcCtD
Labetalol—Sleep disorder—Varenicline—nicotine dependence	0.0211	0.0262	CcSEcCtD
Labetalol—Disorientation—Varenicline—nicotine dependence	0.0204	0.0253	CcSEcCtD
Labetalol—Amnesia—Varenicline—nicotine dependence	0.0195	0.0241	CcSEcCtD
Labetalol—Hypoglycaemia—Varenicline—nicotine dependence	0.0187	0.0232	CcSEcCtD
Labetalol—Lethargy—Varenicline—nicotine dependence	0.0187	0.0231	CcSEcCtD
Labetalol—Affect lability—Varenicline—nicotine dependence	0.018	0.0223	CcSEcCtD
Labetalol—Psychotic disorder—Varenicline—nicotine dependence	0.0179	0.0221	CcSEcCtD
Labetalol—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0177	0.0918	CbGpPWpGaD
Labetalol—Urinary retention—Varenicline—nicotine dependence	0.0174	0.0215	CcSEcCtD
Labetalol—Mood swings—Varenicline—nicotine dependence	0.0173	0.0215	CcSEcCtD
Labetalol—Liver function test abnormal—Varenicline—nicotine dependence	0.0169	0.0209	CcSEcCtD
Labetalol—Abdominal pain upper—Varenicline—nicotine dependence	0.0167	0.0207	CcSEcCtD
Labetalol—Cramp muscle—Varenicline—nicotine dependence	0.0165	0.0204	CcSEcCtD
Labetalol—Angina pectoris—Varenicline—nicotine dependence	0.0154	0.0191	CcSEcCtD
Labetalol—Erectile dysfunction—Varenicline—nicotine dependence	0.0146	0.018	CcSEcCtD
Labetalol—Depression—Varenicline—nicotine dependence	0.0141	0.0174	CcSEcCtD
Labetalol—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0138	0.0717	CbGpPWpGaD
Labetalol—Epistaxis—Varenicline—nicotine dependence	0.0133	0.0165	CcSEcCtD
Labetalol—Bradycardia—Varenicline—nicotine dependence	0.0129	0.016	CcSEcCtD
Labetalol—Hypoaesthesia—Varenicline—nicotine dependence	0.0126	0.0156	CcSEcCtD
Labetalol—Hallucination—Varenicline—nicotine dependence	0.0126	0.0156	CcSEcCtD
Labetalol—Oedema peripheral—Varenicline—nicotine dependence	0.0125	0.0154	CcSEcCtD
Labetalol—Visual impairment—Varenicline—nicotine dependence	0.0122	0.0151	CcSEcCtD
Labetalol—ADRB3—Monoamine GPCRs—DRD2—nicotine dependence	0.012	0.062	CbGpPWpGaD
Labetalol—Mental disorder—Varenicline—nicotine dependence	0.0111	0.0137	CcSEcCtD
Labetalol—Erythema—Varenicline—nicotine dependence	0.011	0.0136	CcSEcCtD
Labetalol—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.011	0.0569	CbGpPWpGaD
Labetalol—Muscle spasms—Varenicline—nicotine dependence	0.0106	0.0131	CcSEcCtD
Labetalol—Vision blurred—Varenicline—nicotine dependence	0.0104	0.0129	CcSEcCtD
Labetalol—Tremor—Varenicline—nicotine dependence	0.0103	0.0128	CcSEcCtD
Labetalol—Ill-defined disorder—Varenicline—nicotine dependence	0.0102	0.0127	CcSEcCtD
Labetalol—ADRB3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0101	0.0521	CbGpPWpGaD
Labetalol—Angioedema—Varenicline—nicotine dependence	0.0101	0.0125	CcSEcCtD
Labetalol—Malaise—Varenicline—nicotine dependence	0.00993	0.0123	CcSEcCtD
Labetalol—Vertigo—Varenicline—nicotine dependence	0.00989	0.0123	CcSEcCtD
Labetalol—Syncope—Varenicline—nicotine dependence	0.00988	0.0122	CcSEcCtD
Labetalol—Palpitations—Varenicline—nicotine dependence	0.00973	0.0121	CcSEcCtD
Labetalol—Loss of consciousness—Varenicline—nicotine dependence	0.00968	0.012	CcSEcCtD
Labetalol—Hypertension—Varenicline—nicotine dependence	0.00951	0.0118	CcSEcCtD
Labetalol—Discomfort—Varenicline—nicotine dependence	0.00926	0.0115	CcSEcCtD
Labetalol—Oedema—Varenicline—nicotine dependence	0.00899	0.0111	CcSEcCtD
Labetalol—Shock—Varenicline—nicotine dependence	0.00884	0.011	CcSEcCtD
Labetalol—Hyperhidrosis—Varenicline—nicotine dependence	0.00869	0.0108	CcSEcCtD
Labetalol—Hypotension—Varenicline—nicotine dependence	0.0084	0.0104	CcSEcCtD
Labetalol—Dyspnoea—Varenicline—nicotine dependence	0.00801	0.00993	CcSEcCtD
Labetalol—Somnolence—Varenicline—nicotine dependence	0.00799	0.0099	CcSEcCtD
Labetalol—Dyspepsia—Varenicline—nicotine dependence	0.00791	0.0098	CcSEcCtD
Labetalol—Fatigue—Varenicline—nicotine dependence	0.00775	0.0096	CcSEcCtD
Labetalol—Pain—Varenicline—nicotine dependence	0.00769	0.00952	CcSEcCtD
Labetalol—Constipation—Varenicline—nicotine dependence	0.00769	0.00952	CcSEcCtD
Labetalol—Feeling abnormal—Varenicline—nicotine dependence	0.00741	0.00918	CcSEcCtD
Labetalol—Gastrointestinal pain—Varenicline—nicotine dependence	0.00735	0.00911	CcSEcCtD
Labetalol—Urticaria—Varenicline—nicotine dependence	0.00714	0.00885	CcSEcCtD
Labetalol—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00711	0.0368	CbGpPWpGaD
Labetalol—Body temperature increased—Varenicline—nicotine dependence	0.0071	0.0088	CcSEcCtD
Labetalol—Abdominal pain—Varenicline—nicotine dependence	0.0071	0.0088	CcSEcCtD
Labetalol—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.00695	0.036	CbGpPWpGaD
Labetalol—Hypersensitivity—Varenicline—nicotine dependence	0.00662	0.0082	CcSEcCtD
Labetalol—Asthenia—Varenicline—nicotine dependence	0.00645	0.00799	CcSEcCtD
Labetalol—Pruritus—Varenicline—nicotine dependence	0.00636	0.00788	CcSEcCtD
Labetalol—Diarrhoea—Varenicline—nicotine dependence	0.00615	0.00762	CcSEcCtD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00597	0.031	CbGpPWpGaD
Labetalol—Dizziness—Varenicline—nicotine dependence	0.00594	0.00736	CcSEcCtD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00584	0.0303	CbGpPWpGaD
Labetalol—Vomiting—Varenicline—nicotine dependence	0.00571	0.00708	CcSEcCtD
Labetalol—Rash—Varenicline—nicotine dependence	0.00567	0.00702	CcSEcCtD
Labetalol—Dermatitis—Varenicline—nicotine dependence	0.00566	0.00702	CcSEcCtD
Labetalol—Headache—Varenicline—nicotine dependence	0.00563	0.00698	CcSEcCtD
Labetalol—Nausea—Varenicline—nicotine dependence	0.00534	0.00661	CcSEcCtD
Labetalol—ADRB3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00495	0.0256	CbGpPWpGaD
Labetalol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00456	0.0236	CbGpPWpGaD
Labetalol—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0045	0.0233	CbGpPWpGaD
Labetalol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0037	0.0192	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0032	0.0166	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00294	0.0152	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00287	0.0149	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0028	0.0145	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00274	0.0142	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00254	0.0132	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00231	0.012	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—FGD1—nicotine dependence	0.00219	0.0114	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—OPRM1—nicotine dependence	0.00209	0.0108	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00208	0.0108	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—FGD1—nicotine dependence	0.00199	0.0103	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00198	0.0103	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00196	0.0102	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00194	0.01	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0019	0.00983	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00186	0.00961	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00166	0.0086	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00163	0.00842	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00162	0.00841	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00159	0.00824	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD2—nicotine dependence	0.00151	0.00781	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00151	0.00781	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TAS2R16—nicotine dependence	0.0015	0.00777	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00147	0.00764	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00137	0.00711	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00134	0.00695	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.0013	0.00675	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00127	0.0066	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.00124	0.00641	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00121	0.00627	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.00118	0.00613	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00118	0.00611	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGD1—nicotine dependence	0.00118	0.0061	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00117	0.00609	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00116	0.00599	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00115	0.00596	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—OPRM1—nicotine dependence	0.00107	0.00554	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKR1B10—nicotine dependence	0.00104	0.00539	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000895	0.00464	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.00089	0.00461	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.000875	0.00454	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.000871	0.00451	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD2—nicotine dependence	0.000852	0.00441	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD2—nicotine dependence	0.000774	0.00401	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—WASF2—nicotine dependence	0.000732	0.00379	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—WASF1—nicotine dependence	0.000702	0.00364	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000699	0.00362	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000698	0.00362	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000684	0.00354	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000683	0.00354	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000635	0.00329	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—OPRM1—nicotine dependence	0.000632	0.00328	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000621	0.00322	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000617	0.0032	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000603	0.00313	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000506	0.00262	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000495	0.00256	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000459	0.00238	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD2—nicotine dependence	0.000457	0.00237	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000449	0.00233	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000435	0.00225	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000425	0.0022	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.000417	0.00216	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000408	0.00211	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000375	0.00194	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.000367	0.0019	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000336	0.00174	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000271	0.00141	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.000265	0.00137	CbGpPWpGaD
